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ABSTRAK 
 
Tajuk 
Aktiviti antikulat tiga madu tempatan Malaysia ke atas kulat patogen terpilih penyebab 
penyakit otomikosis; kajian di dalam makmal. 
 
Pengenalan  
Madu telah digunakan sebagai makanan dan produk perubatan sejak zaman purba. Ciri 
antibakteria madu mendominasi dan didokumenkan secara meluas. Sebaliknya pula, 
keberkesanan antikulat terhad digambarkan. Tambahan pula, kebelakangan ini juga, 
terdapat peningkatan kekebalan terhadap ubat antikulat. Ini mendorong keperluan untuk 
menyelidik bahan semula jadi yang lebih berkesan dan selamat. Madu sejenis bahan 
semulajadi, berjaya menarik minat potensi antikulat. Terdapat pelbagai jenis madu 
tempatan di Malaysia. Walau bagaimanapun, sehingga kini, tiada kajian yang 
menyeluruh kesan antikulat madu-madu tersebut dilaksanakan. Oleh itu, kajian ini 
menilai kesan antikulat tiga jenis madu Malaysia terhadap dua kulat penyebab utama 
penyakit otomikosis. Ketiga-tiga madu yang digunakan dalam kajian ini adalah unik.  
Tualang adalah sejenis madu multiflora. Sementara, Akasia adalah sejenis madu 
diantara bebunga dan Kelulut pula adalah madu dari lebah tanpa sengat.  
 
Objektif 
Untuk menyiasat kesan antikulat tiga jenis madu Malaysia (Akasia, Kelulut dan 
Tualang) terhadap Aspergillus niger dan Candida albicans. Kajian ini juga 
menunjukkan madu dengan kesan antikulat terkuat. 
 
Metodologi 
Ini adalah kajian prospektif makmal yang dikawal. Tiga jenis madu Malaysia dalam 
beberapa kepekatan yang berbeza, dikaji dalam makmal untuk aktiviti anti kulat 
terhadap Aspergillus niger dan Candida albicans. SDA disediakan bersama madu dalam 
empat kepekatan yang berbeza; 5 peratus (w/v), 10 peratus (w/v), 15 peratus (w/v) dan 
25 peratus (w/v), yang bertindak sebagai media. Bilangan koloni diatas media SDA 
sahaja dibandingkan dengan media SDA bersama madu. Ujian statistik “Paired t-Test” 
dan “Wilcoxon Signed Rank Test” dijalankan.  
 
xii 
 
Keputusan 
Di dalam makmal, ketiga-tiga madu Malaysia mempunyai kesan antikulat yang 
signifikan ke atas dua kulat patogen utama penyakit otomikosis. Tualang dan Akasia 
mempunyai kepekatan yang sama untuk aktiviti antikulat terhadap kedua-dua kulat iaitu  
pada kepekatan 10 peratus (w/v). Sementara itu Kelulut telah mula menunjukkan kesan 
antikulat pada kepekatan serendah 5 peratus (w/v). Keberkesanan antikulat bagi ketiga-
tiga madu adalah berkadar terus dengan kepekatan, sehingga tahap perencatan penuh 
terhasil. Kepekatan perencatan penuh bagi kedua-dua kulat adalah sama bagi setiap 
madu berasingan kecuali madu Akasia. Akasia memerlukan kepekatan yang lebih tinggi 
untuk perencatan Aspergillus niger iaitu 15 peratus (w/v) berbanding hanya 10 peratus 
(w/v) bagi Candida albicans. Perencatan sepenuhnya bagi Kelulut adalah 10 peratus 
(w/v) sementara Tualang  adalah pada 25 peratus (w/v). Antara ketiga-tiga madu yang 
diuji, Kelulut menunjukkan kesan antikulat paling signifikan terhadap kedua-dua kulat. 
 
Kesimpulan 
Kajian ini menunjukkan, di dalam makmal tiga madu Malaysia mempunyai kesan 
antikulat terhadap kulat patogen utama penyakit otomikosis. Oleh itu, ia berpotensi 
sebagai sumber alternatif dalam rawatan otomikosis. 
 
Kata kunci : Madu Malaysia, Otomikosis, Aspergillus niger, Candida albicans, 
Tualang, Kelulut, Akasia 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
ABSTRACT 
 
Title 
Antifungal activity of three local Malaysian honeys on selected pathogenic fungi of 
otomycosis; an in vitro evaluation.  
 
Introduction 
Honey has been used as foods and medicinal products since ancient times. Its 
antibacterial properties has extensively documented. Contrarily, limited antifungal 
efficacy of honey was illustrated. Furthermore, in recent years, there are increasing in 
the antifungal drugs resistance. This drives the need to pursuit for natural solution 
which is more effective and safe. Honey, a natural solution attracted interest of its 
potential antifungal effect. They are various types of Malaysian honey. However, to 
date, no extensive studies on it antifungal properties have been conducted. Hence, this 
study evaluates antifungal effect of three Malaysian honeys against two most common 
pathogenic fungi of otomycosis. All honeys used in this study are unique. Tualang is a  
multifloral honey. Meanwhile Akasia are extraflorial honey and Kelulut are honey from 
stingless bee. 
 
Objectives 
To investigate the antifungal action of three types of Malaysia honeys (Akasia, Kelulut 
and Tualang) against Aspergillus niger and Candida albicans. This study also 
investigates honey with strongest antifungal effect. 
 
Methodology and study design 
This is a laboratory-controlled prospective study. Different concentrations of three types 
of Malaysian honey studied in vitro for their anti fungal activity on fungal isolates of 
Aspergillus niger and Candida albicans. Four different concentrations of SDA media 
incorporated with honey; 5 percent (w/v), 10 percent (w/v), 15 percent (w/v) and 25 
percent (w/v) act as media. The numbers of colonies on SDA media alone were 
compared with SDA with honey. Statistical test of Paired t-Test and  Wilcoxon Signed 
Ranks Test applied.  
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Results 
In vitro, all three Malaysia honeys used, has significant antifungal effects on two most 
common pathogenic fungi of otomycosis. Tualang and Akasia have equal concentration 
for antifungal effect towards both fungi at 10 percent (w/v). Meanwhile Kelulut already 
demonstrate the effect at 5 percent (w/v). The antifungal efficacy is proportionate to 
concentration of all three honeys proceeding to total inhibition. Total inhibition noted to 
be equal for both Candida albicans and Aspergillus niger, for each individual honey 
except Akasia. Akasia need higher concentration for total inhibition of Aspergillus 
niger; 15 percent (w/v) compare to Candida albicans at 10 percent (w/v). For Kelulut it 
was at 10 percent (w/v) and Tualang at 25 percent (w/v). Among three honeys tested, 
Kelulut demonstrates the strongest antifungal effect towards both fungi. 
 
Conclusion 
This study demonstrates in vitro antifungal activity of three Malaysian honeys against 
two known pathogenic fungi of otomycosis. Hence, it has potentials as alternative 
agents in the treatment of otomycosis.  
 
Keywords : Madu Malaysia, Otomikosis, Aspergillus niger, Candida albicans, 
Tualang, Kelulut, Akasia 
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CHAPTER 1 
 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 OTOMYCOSIS 
 
1.1.1 DEFINITION 
Otomycosis or otherwise known as otitis externa of fungal etiology is a chronic 
or subacute infection of the pinna, the external auditory meatus and the ear canal (Chin 
and Jegathesan, 1982). It was defined as superficial mycotic (fungal) infection of the 
outer ear canal (Dorland‟s, 2012). Gil-Carcedo et al. (2004) defined it more precisely as 
subacute or chronic infections produced by yeast and filamentous fungi that affect the 
squamous epithelium of the external auditory canal.    
 
1.1.2 EPIDEMIOLOGY 
In the past there were controversies regarding the prevalence and even existence 
of otomycosis. The debate was whether the fungi are true infective agents.  Some 
believe it was mere fungal colonization due to compromised local host immunity 
secondary to bacterial infection but are of no etiological association (Kingery, 1965) 
and others doubt fungi are capable of producing inflammatory process, and only accept 
them as secondary invaders (Youssef and Abdou, 1967). Conant et al. (1954) proposed 
that not more than 15 to 20 percent of the ear infections are true otomycosis. Despite the 
widely divergent opinions, at this current era, the weight of the evidence in the 
literature, based on clinical and laboratory study, supports otomycosis as a true 
pathologic entity (Chin and Jegathesan, 1982; Ho et al., 2006; Paulose et al., 1989; 
Zaror et al., 1991). 
 
Many different data published regarding magnitude of otomycosis. Carney 
(2008) documented otomycosis affect 10 percent of the population in their lifetime. It 
accounts for approximately 9 to10 percent of all cases of otitis externa, (Bojrab et al., 
1996; Ho et al., 2006; Stern et al., 1988) and as high as 30.4 percent in patient with 
inflammatory conditions of the external auditory meatus (Kurnatowski and Filipiak, 
2001).  
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Otomycosis has a world-wide distribution, with higher prevalence at tropical and 
sub-tropical regions that has hot, humid and dusty climate (Carney, 2008; Kumar, 2005; 
Munguia and Daniel, 2008; Paulose et al., 1989) between second and third decade of 
life (Kumar, 2005; Paulose et al., 1989). However studies pertaining prevalence of 
otomycosis remains scant, despite of its high occurrences especially from those 
countries in the tropical region. In Malaysia, way back in 1982, Chin and Jegathesan 
(1982) had published fungal isolates from suspected cases of otomycosis over a period 
of twelve years; 1969 till 1981. However their study do not reveal incidence of 
otomycosis during this period. Meanwhile in Singapore, Ong and Chee (2005) has 
published an article on infections of the external ear, also did not document magnitude 
of otomycosis either. The study that was conducted by Zaror et al. (1991) in Brazil, 
highlights several facts namely, limited prior studies in this area at Brazil, despite being 
a country with tropical climate and secondly, 90 percent from clinically suspected case 
were confirmed to have otomycosis. In Bahrain, Paulose et al.(1989) found 6 percent of 
patient with symptoms of ear disease seen at their outpatient clinics has otomycosis. 
Clearly, the incidence of otomycosis remains limited and their finding varies across 
countries.  
 
There were very scanty researches that look into gender preponderance. 
Different results were reported. Kumar (2005) reported males and females were almost 
equally affected. However Paulose et al. (1989) and Ho et al. (2006) documented very 
slim preponderance for male. Contrarily Zaror et al. (1991) report higher incidence 
(65%) in female. 
 
Otomycosis is predominantly a unilateral disease, although small percentages 
(7-20.8%) of bilateral cases were reported (Ho et al., 2006; Kurnatowski and Filipiak, 
2001; Mugliston and O‟ Donoghue, 1985; Paulose et al., 1989; Zaror et al., 1991). 
 
1.1.3 ANATOMY, PHYSIOLOGY AND MICROBIOLOGY OF EXTERNAL EAR 
CANAL IN RELATION WITH OTOMYCOSIS. 
The external auditory canal extends from concha of the auricle to the tympanic 
membrane and is approximately 2.4 cm long. The supporting framework of the canal 
wall is cartilage in the lateral one third (8 mm) and bony in the medial two thirds (16 
mm). There are two intrusions into the canal, formed by suture lines. This two suture 
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lines are tympanoquamous anteriorly and tympanomastoid posteriorly which project 
into the canal making ear toilet in a patient with otomycosis a challenge.  
 
Apart from intrusions, there are also two constrictions; at the bony cartilaginous 
junction and isthmus. The isthmus is a constriction located 5mm from tympanic 
membrane and beyond the isthmus presents a recess called anterior recess. Anterior 
recess is the anteroinferior portion of the canal, dips in between the tympanic membrane 
and canal, forming a wedge-shaped recess. The anterior recess acts as cesspool for 
discharge, keratin debris and cerumen. Furthermore this recess is a difficult spot for 
access either for procedure in the office setting or during surgery because it is a hidden 
area due to the presence of constriction (isthmus), making it difficult for cleaning, thus 
favour colonization by fungus.  
 
The skin of external segment is hairy and has sebaceous and ceruminous gland. 
It is also more adherent than skin of the internal segment. The glandular secretions 
mixed with flaked cellular epithelial elements to form an acidic ceruminous substance 
which is hydrophobic, making it capable of repelling water. As a result, the canal is 
impermeable and thus avoiding maceration and epithelial damage. Cerumen consists of 
lipids, proteins, free amino acids and mineral ions. It also contains lysozyme, 
immunoglobulins and fatty polyunsaturated acids. The long-chain fatty acids present in 
unbroken skin inhibit microorganism growth. Thus, the areas of skin that take part in 
cerumen production have all the components of an active local immune system and 
protect the canal by an antibody-mediated local immune response (Mugliston and O‟ 
Donoghue, 1985; Sirigu et al., 1997). Basically, cerumen has both antimycotic and 
bacteriostatic properties. Otomycosis occurs  because  the protective lipid/acid balance  
of the ear is  lost, as once the ear becomes inflamed, healthy cerumen rapidly removed 
from  the  ear  and  is  no  longer  produced (Carney, 2008; Paulose et al., 1989; Zaror et 
al., 1991). Contrarily, some authors advocate that with the presence of cerumen, acting 
as a support for fungal growth (Mugliston and O‟ Donoghue, 1985; Munguia and 
Daniel, 2008).  
 
The microbial flora of the external auditory canal is usually commensal or non-
pathogenic comprising of Staphylococcus epidermis, Corynebacterium spp, Bacillus 
spp, Gram-positive cocci (Staphylococcus aureus, Streptococcus spp and non-
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pathogenic micrococci), Gram-negative bacilli (Pseudomonas aeruginosa, Eschericia 
coli, Haemophilus influenza, Moraxella cararralis) and mycelial fungi of the 
Aspergillus genus or yeast-like fungi, particularly Candida spp. As long as the balance 
between bacteria and fungi is maintained, this commensal flora remains non-pathogenic 
(Murray, 1995). The fungal colonization of the external auditory canal is not permanent 
but temporary probably related to environmental changes as was noted when healthy 
people and patients were studied over time (Hueso et al., 2005). Local lesion observed 
in otitis, leads to inflammation process, resulting in edema which entrap water and 
moisture in the ear canal. Thus cerumen is no longer produced. Water and moisture also 
lead to shift from a predominantly Gram-positive skin flora to a Gram-negative one. 
The balance is disturbed. With further edema and scratching, there is disruption of the 
epithelial layer and invasion of resident or introduced organism occur (Carney, 2008).  
 
The pH of the normal ear canal is on the acidic site of neutrality (5-7) and 
Aspergilli have optimum growth in pH within this range (Yassin et al., 1964). 
Maximum growth rates for Aspergilli were at 37
0
C. All this facts clinically support the 
predilection of the fungi to grow at inner one third of the ear canal which has 
temperature near to core body temperature (Yassin et al., 1964). 
 
In summary, Conley (1948) beautifully concluded that the external ear canal 
fulfills many of the requirements for fungal growth; where the environmental factor 
being essentially warmth, moist with optimum pH.   
 
1.1.4 CAUSATIVE AGENTS 
Many species of fungi have been identified as a cause of otomycosis (Munguia 
and Daniel, 2008; Stern et al., 1988). However the most implicated fungi in otomycosis 
is  Aspergillus species and secondly by Candida species (Bojrab et al., 1996; Carney, 
2008; Chin and Jegathesan, 1982; Ho et al., 2006; Kiakojuri et al., 2007; Munguia and 
Daniel, 2008; Ong and Chee, 2005; Paulose et al., 1989; Stern et al., 1988; Zaror et al., 
1991). Munguia and Daniel (2008) have done extensive literature review on otomycosis 
from 1951 to 2007. They concluded Aspergillus niger is the most commonly described 
agent in the literature, followed by Candida albicans (Bojrab et al., 1996; Carney, 2008; 
Ho et al., 2006; Kiakojuri et al., 2007; Munguia and Daniel, 2008; Ong and Chee, 2005; 
Paulose et al., 1989; Zaror et al., 1991). However Stern et al. (1988) describes 
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predominant fungal based on climate; where Aspergillus niger is the major isolate in 
tropical zones where else Candida albicans is more common at temperate zones.  
 
Aspergillus niger belongs to the molds are saprobes which grow as long tangled 
strands of cells that give rise to visible colonies (Figure 1.1). Contrarily Candida 
albicans belongs to the yeast sub-division and which are unicellular. The colonies 
resemble bacterial colonies (Figure 1.2). Otomycosis attributed to Candida is often 
identified by culture data, as it is lack of characteristic appearances clinically, unlike 
Aspergillus (Ho et al., 2006).  
 
 
Figure 1.1: Gross appearance of Aspergillus niger on Saboraud Dextrose Agar (SDA) 
plate showing black colonies. 
(Source: www.pgodoy.com/aspergillus_niger)  
 
 
Figure 1.2: Gross appearance of Candida albicans on Saboraud Dextrose Agar (SDA) 
plate showing whitish colonies. 
(Source : www.static.ddmcdn.com/candida_albicans) 
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In Malaysia, little has been done in the way of characterization of the etiological 
agents, thus Chin and Jegathesan (1982) performed mycological study for 12 years 
duration, on clinically suspected cases of otomycosis.  It showed 74.6 percent positive 
fungal isolation. Aspergillus (78.4%) was the most predominant genus isolated and 
Candida, the next. 
 
Various incidence of mixed fungal infection were also reported; ranging from as 
low as 7.3 per cent (Chin and Jegathesan, 1982) to 28 per cent (Youssef and Abdou, 
1967). Bacterial co-infection was also discussed (Kumar, 2005). Among commonly 
isolated bacteria includes coagulase-negative staphylococci (CONS), Pseudomonas sp., 
Staphylococcus aureus, E. coli and Klebsiella sp. (Kumar, 2005). 
 
The importance of fungal culture cannot be understated (Stern et al., 1988). Chin 
and Jegathesan (1982) and Kurnatowski and Filipiak (2001) advocate cultural 
confirmation of all cases. This is to apply most adequate treatment, prevent 
mismanagement, relapses and for better knowledge on otomycosis and the causative 
agents. Therapeutically, most authors believe that it is important to identify causal agent 
of otomycosis in order to use appropriate treatment, where antimycotic treatment 
chosen should be based on susceptibility of the identified species (Arthur et al., 2004; 
Bassiouny et al., 1986; Munguia and Daniel, 2008; Stern et al., 1988). Contrarily, 
others proposed regardless of the causative agents, important strategy is to select 
specific treatment based on efficacy of the drugs (Araiza et al., 2006; Blyth et al., 2007; 
Munguia and Daniel, 2008). 
 
1.1.5 RISK FACTORS 
Very often otomycosis manifest only in the presence of predisposing factors. 
Some identified culprits include hot, humid climates and is often secondary to 
prolonged treatment with topical antimicrobials (Carney, 2008; Ho et al., 2006; Kumar, 
2005; Munguia and Daniel, 2008). However, no specific ototopical antimicrobial 
preparation appears to link with higher development of otomycosis (Ho et al., 2006). 
There appear to be little consensus with respect to the predisposing factors. For 
instance, when most of the researches blame widespread usage of antibiotics, some 
authors suggest higher incidence of otomycosis is not related with usage of topical or 
systemic antibiotics and steroids (Mugliston and O‟ Donoghue, 1985; Paulose et al., 
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1989). Several recent articles also established the potential risk of autoinoculation of the 
ear canal by patients suffering dermatomyosis, while other disagrees (Ho et al., 2006; 
Kumar, 2005).   
 
Diabetes and immune-compromised state also increase the risk of developing 
otomycosis (Carney, 2008; Ho et al., 2006; Kumar, 2005; Munguia and Daniel, 2008; 
Ong and Che, 2005). Hormonal changes as seen during menstruation or pregnancies 
precipitate infection (Kumar, 2005; Munguia and Daniel, 2007).  
 
Other factors include presence of mastoid cavities, hearing aids with occlusive 
molds, fungal infections elsewhere in the body like dermatomycosis or vaginitis, trauma 
and bacterial infections (Carney, 2008; Kumar, 2005).  
 
Prior otologic procedures also appear to increase the risk (Ho et al., 2006). 
Several factors contribute to this. Recurrent drainage or subsequent topical 
antimicrobial or antiseptic may alter the local environment and microbial flora; thus 
allow superinfection by nosocomial fungi. Surgical procedures also alter the anatomy of 
ear canal that affect cerumen production or relative humidity that favor fungal growth 
(Ho et al., 2006).  
 
1.1.6 CLINICAL FEATURES 
Clinically, the most common presenting complaints were otalgia and otorrhea, 
followed by hearing loss, aural fullness and pruritus (Ho et al., 2006; Munguia and 
Daniel, 2007). Aural fullness and hearing loss occurs secondary to accumulation of 
fungal debris in the canal.  Pruritus has been frequently reported as one of the hallmark 
symptom in otomycosis (Kiakojuri et al., 2007; Kumar, 2005; Kurnatowski and 
Filipiak, 2001; Ong and Chee, 2005).  
 
On otoscopic examination, the most common finding is a black, green, grey, 
yellow or white discharge with musty odor and debris, that is often said resemble wet 
newspaper (Carney, 2008). Sometimes the debris is seen with visible fungal hyphae. 
Aspergillus niger appears as black-headed filamentous growth (Figure 1.3), where else 
Candida albicans as white or creamy deposits (Figure 1.4).  
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Otomycosis can usually be diagnosed by clinical examination and often occurs 
in persistent otorrhea (Ho et al., 2006). Chin and Jegathesan (1982) concluded that 
clinical presentation often allows diagnosis to be made with fairly good accuracy when 
they found 74.6 percent yield fungal growth. However diagnosis of otomycosis caused 
by Candida albicans can be very difficult because of lack of its characteristic 
appearance like Aspergillus. It can present as otorrhea not responding to aural 
antimicrobials and is often identified by laboratory culture study (Ho et al., 2006). 
Basically, high index of suspicion is required for correct diagnosis of otomycosis as the 
presenting complaints are relatively non-specific.   
 
 
Figure 1.3: Otomycosis caused by Aspergillus niger 
(Source:www.eac.hawkelibrary.com/otomycosis) 
 
Figure 1.4: Otomycosis caused by Candida albicans 
(Source:www.eac.hawkelibrary.com/otomycosis) 
 
1.1.7 MANAGEMENT 
Treatment with antifungal agents is not enough to ensure complete treatment and 
should aim at restoring the physiology of the external auditory canal (Hueso et al., 
2005). Ear toilet with removal of the debris and topical antifungal is the customary 
treatment (Carney, 2008).  
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Reviewed literature emphasized on ear toilet and aural hygiene. It can be done 
either by suctioning or mopping. Ear toilet removes all the discharges and epithelial 
debris which are conducive for the growth of fungus. Ototopical medications also only 
work best following removal of secretions or debris (Ho et al., 2006; Munguia and 
Daniel, 2007).  
 
To date, there are four main classes of drugs for the treatment of fungal 
infections: polyenes, triazoles, nucleoside analogues, and echinocandins. The polyenes 
family includes amphotericin B and nystatin. The triazoles family, better known as 
azoles includes clotrimazole, miconazole, and fluconazole. Mean while flucystosine is 
an example of nucleotide synthesis. Echinocandins are a novel class of antifungal agent, 
however their usage in otomycosis has not been reported (Munguia and Daniel, 2008). 
Munguia and Daniel (2008), based on their literature review for period of 56 years also 
found antifungal from the azole class seem to be the most effective for otomycosis, 
followed by nystatin and tolnaftate.  
 
Many agents have been recommended, but no preparation has been widely 
accepted and there seems to be no consensus as to which medications are the most 
effective. To date there is no FDA-approved antifungal otic preparation for the 
treatment of otomycosis. Clinicians have struggled to identify the most effective agent. 
However use of few topical antifungal has persisted throughout time, including nystatin 
and the azoles family (Bassiouny et al., 1986; Ho et al., 2006; Kiakojuri et al., 2007; 
Paulose et al., 1989).  
 
Treatment of otomycosis varies among different authors. For an instance, one 
study showed that clotrimazole and econazole had broad-spectrum antifungal activity; 
inhibiting both yeasts and moulds, and therefore should be the treatment of choice for 
otomycosis. It may be safely used as otic drops (Bassiouny et al., 1986). Meanwhile, 
Stern et al. (1988) claimed among topical antifungal agents, clotrimazole and nystatin 
have the widest spectrum of activity.  
 
As a conclusion, there is no consensus on the most effective antifungal agent, 
although multiple in vitro studies have examined the efficacy of various antifungal 
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agents (Kurnatowski and Filipiak, 2001). However, various agents have been used 
clinically with variable success rates (Paulose et al., 1989).  
 
Oral antifungal is reserved for cases with severe disease and poor response to 
therapy, though rarely necessary. Oral antifungal are unlikely to succeed in the absence 
of adequate local care of ear canal (Ho et al., 2006). 
 
In cases of resistant otomycosis, it is prime important to exclude fungal infection 
elsewhere, including athlete‟s foot (Carney, 2008). The „foot and ear‟ reaction can cause 
recurrent otomycosis if the primary fungal infection elsewhere remains untreated 
(Busch, 1998). Ho et al. (2006) also reported higher recurrent and residual disease rates 
in the presence of mastoid cavity.  
 
In immune-compromised patients, rarely fungi can cause invasive otitis externa. 
There‟s often high mortality rate from this condition (Harley et al., 1995). In such 
patients, aggressive systemic antifungal therapy is required (Cunningham et al., 1988).  
 
1.1.8 THE CHALLENGE  
Otomycosis is not a life threatening ailment, but can be a very frustrating disease 
for both patient and physician. Although rarely life threatening, patients frequently 
requires long term treatment and follow-up, yet recurrence rate remains high (15%) (Ho 
et al., 2006). These pose challenges and frustration for both patients and 
otolaryngologists. 
 
The literature indicates that antifungal medications vary widely and there seems 
to be no consensus as to which medications are most effective in otomycosis 
(Kurnatowski and Filipiak, 2001; Lawrence et al., 1978). This is due to the resistance 
pattern of the implicated fungi to the various available anti-fungal agents. It was shown 
that antifungal solutions, such as clotrimazole or nystatin may be effective against 
Candida but not Aspergillus. Ruckenstein (2005) recommended treatment of with oral 
itraconazole. Where else Bassiouny et al. (1986) strongly recommend both econazole 
and clotrimazole otic drop should be used worldwide. This was based on broad-
spectrum antifungal activity, well tolerated and with no side effects. Both of these drugs 
also possess the advantage of having an antibacterial effect in addition to their 
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antifungal action (Lawrence et al., 1978). This added advantage when treating mixed 
infection. Munguia and Daniel (2008), in their extensive literature review from January 
1951 till March 2007, found clotrimazole is the most widely used and effective topical 
medication with effectiveness from 95 percent to 100 percent in most studies.    
 
It is remarkable how many medications have been used for this stubborn 
condition (Kurnatowski and Filipiak, 2001; Munguia and Daniel, 2008; Paulose et al., 
1989). Nevertheless, treatment with antifungal agents alone is not enough to ensure 
complete treatment. It should be coupled with mechanical debridement, which aims at 
restoring the physiology of the external auditory canal (Ho et al., 2006; Hueso et al., 
2005).  
 
It is generally understood, that fungus grows into the squamous epithelium of 
the external auditory canal (Gil-Carcedo et al., 2004). Keratolytic or antiseptic/acid ear 
drops removes superficial layers of dermis, and along with that, the fungal mycelia 
growing into them. Thus research that looks into role of this agents, have also been done 
(Kiakojuri et al., 2007; Munguia and Daniel, 2008).  Ozcan et al. (2004) concluded that 
administration of 4 per cent boric acid solution in alcohol and frequent suction cleaning 
of the ear canal might be a cost-effective treatment for otomycosis as 77 per cent of the 
patients were treated effectively.  While Kiakojuri et al. (2007) reveal no significance 
difference between group that undergoes suction clearance and application of topical 
miconazole compared with another group that received same combination with 3 per 
cent acetic acid drops.  
 
1.2 HONEY 
 
1.2.1 Honey and origin 
Honey has been used as food and medicinal products since the earliest time. It is 
the natural substance produced by the honey bees Apis spp., from the nectar or blossom 
or exudates of trees and plants giving nectar honey or honeydew respectively (Alvarez-
Suarez et al., 2010; Molan, 1992).  
 
As the only available natural sweetener, honey was an important food for Homo 
sapiens from the very beginning. It was an important source of carbohydrates and the 
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only widely available sweetener, until the production of industrial sugar began to 
replace it after 1800 (Crane, 1975). In the long human tradition, honey has been used 
not only as nutrient but also as a medicine. Indeed, the relationship between bees and 
humans started as early as Stone Age. The first written reference to honey was found on 
a Sumerian tablet dating back 2100-2000 BC, mentioning the use of honey as drugs and 
ointment (Crane,1975). As stated in the Holy Quran verses 16:68-69, “And your Lord 
inspired the bee, saying “take your habitations in the mountains and the trees, and in 
what they erect. Then, eat of all fruits, and follow the ways of your Lord made easy (for 
you)”. There comes forth from their bellies, a drink of varying colours wherein is 
healing for men. Verily, in this indeed a sign for people who think.” (Holy Quran, An-
Nahl, 16 : 68-69). 
 
Honey has been used in many cultures since ancient time for its medicinal 
properties, including as a remedy for burns, cataracts, ulcers and wound healing 
(Alvarez-Suarez et al., 2010; Coulston, 2000). Aristotle, 350 BC and Dioscorides, AD 
50 recommended that honey collected in specific regions and seasons to be used for the 
treatment of different ailments (Molan, 1992). Ibne Sina, the prince among Muslim 
physicians, in his work, “The Canon of Medicine”, listed several beneficial uses of 
honey (Crane, 1975). Such considerations have continued into present day. The 
strawberry tree honey of Sardinia is valued for its therapeutic properties while in India 
lotus honey is used for eye diseases (Molan, 1992). 
 
1.2.2 Properties of honey 
The quality of honey depends on the composition of nectar and floral origin. The 
active component in plants depends on various factors too; plant-bio, chemotype and 
climatic conditions. Consequently, honey properties from different locations should be 
different (Alvarez-Suarez et al., 2010; Cushnie and Lamb, 2005; Koc et al., 2009). 
 
Honey is mainly made up of carbohydrates which constitute about 95% of its 
dry weight. It contains at least 181 substances (Chow, 2002). It is a supersaturated 
solution of sugars, mainly composed of fructose (38%) and glucose (31%), containing 
also minerals, proteins, free amino acids, enzymes and vitamins (Perez et al., 2002; 
Terrab et al., 2003). A wide range of minor constituents are also present in honey. 
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These include phenolic acids and flavanoids, certain enzymes (glucose oxidase, 
catalase) and amino acids.  
 
The concentration and type of polyphenolic substances depend on the floral 
origin of honey, and are major factors responsible for producing numerous nutritional 
and biological effects. That includes antifungal, antiviral, antibacterial, antioxidant, 
anti-inflammatory, anti mutagenic and immunosuppressive activities (Ahmed and 
Othman, 2013; Alvarez-Suarez et al., 2010; Cushnie and Lamb, 2005; Koc et al., 2009). 
Benzoic acid, cinnamid and flavanoid are mains polyphenolic.  
 
1.2.3 HONEY IN MEDICINE 
The belief that honey could be used as nutrient, a drug and an ointment has 
continued to the present time. Currently, information on the use of honey for the 
treatment of many human diseases can be found in general magazines, bee-keeping 
journals and natural products leaflets, suggesting a wide variety of unfounded 
properties. An alternative medicine branch, called apitherapy has developed in recent 
years. Apitherapy or therapy with bee products is an age-old therapeutic practice as 
recorded by several ancient civilizations. Indeed, medicinal importance of honey has 
been documented in the world‟s oldest medical literatures (Crane, 1975; Maryann 
2000). In light of modern science, several important therapeutic effects of honey have 
been elucidated. Modern science has made it possible to specify their medical 
significance as bactericidal, bacteriostatic, antiviral, antifungal, antioxidant, anti-
inflammatory, and antitumoral (Ahmed and Othman, 2013; Alvarez-Suarez et al., 2010; 
Cushnie and Lamb, 2005; Koc et al., 2009; Tan et al., 2009).  
 
The antibacterial activity of honey was first reported by Van Ketel in 1892 and 
the next report was by Sackett in 1919 (Molan, 1992). They also reported  that  the  
antibacterial  potency  was  increased  by  limited  dilution  of  honey, an  observation  
that  was  hard  to  explain. Its antibacterial action is effective against a very broad 
spectrum of species. It is postulated osmotic action secondary to high sugar content of 
honey, hydrogen peroxide action by enzymatic activity in honey and acidity pH of 
honey are responsible for this effect (Molan, 1992; Tan et al., 2009). However 
mechanism of antifungal activity is still not clearly understood yet as fungi are inhibited 
under conditions where the sugar content of the honey is clearly not responsible unlike 
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bacteria (Molan, 1992). To date, very few attempts have been made to assess the 
antifungal properties of honey, compared to the large volume of published literature 
which has established that honey has significant antibacterial activity (Alvarez-Suarez 
et al., 2010; Aween et al., 2012a; Aween et al., 2012b; Mohamed et al., 2010; Molan, 
1992; Tan et al., 2009; Tumin et al., 2005).   
 
There are different types of honey available globally with potential beneficial 
medicinal products. There are countries with different types of honey bearing different 
properties such as Manuka honey of New Zealand, Brazilian Acasia honey and locally 
available Malaysian honey such as Tualang, Kelulut, Gelang emas, Akasia and Pucuk 
Daun. To date, most of the study in Malaysia concentrates on various properties and 
benefit of Tualang and its other effect such as antibacterial and antitumour (Ahmed and 
Othman, 2013; Aween et al., 2012a; Aween et al., 2012b; Fauzi et al., 2011; Ghashm et 
al., 2010; Halima et al., 2010; Kannan et al., 2009; Khalil et al., 2011a; Khalil et al., 
2011b; KirnpalKaur et al., 2011; Kishore et al., 2011; Mohamed et al., 2010; Nasir et 
al., 2010; Tan et al., 2009; Tumin et al., 2005).  
 
1.2.4 MALAYSIAN HONEY 
Honey is a prized delicacy to the Malaysians, particularly among the Malays. 
For centuries honey is known to be the enemy of diseases. There is a special Malay 
recipe for treatment of asthma using egg, lime juice and honey. It is also used in the 
preparation of the famous traditional Malay herbal remedy “ubat periuk” for post natal 
care. Honey also found to be effective in curing burns, carbuncle, boils and diabetic 
wound.  
 
They are long list of Malaysian honey available, examples are “Tualang”, 
“Hutan”, “Gelang”, “Pucuk Daun”, “Ee Feng Gu”, “Kelulut” and “Akasia”.  
 
Tualang honey is extracted from honeycombs from the Asian Rock bees (Apis 
dorsata) which build their hives high up in the Tualang tree (Koompassia excelsa).  
Tualang tree is Malaysia‟s tallest tree, which grows to an astonishing height of more 
than 250m (about 30 storeys) and found in East Asian rainforest and is most found in 
low land rain forest of Peninsular Malaysia, Southern Thailand, North Eastern Sumatera 
and Borneo.  The sources of nectars are multifloral.  
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Kelulut honey is extracted from honeycombs of Kelulut bees (Trigona spp). 
Kelulut bees are the smallest bees and are more of a „house bee‟. This bee is unique as it 
is the only bee which stingless. The Malays considered these small bees have more 
medicinal powers. 
 
Akasia honey (honey-dew honey) is extracted from honeycombs of Apis 
mellifera. The source of nectar is extraflorial; in between leaf of Acacia tree (Acacia 
mangium). Acacia tree is tree native to Australia and were brought to Malaysia for 
timber and pulp production to be used for paper production.    
 
Among variety of local honey available, this study will focus on three (3) types 
of honey, namely Tualang, Akasia and Kelulut for few reasons. Tualang honey has been 
well-known for its healing and therapeutic effect. Most of the study in Malaysia, 
incorporated Tualang as the major honey in their research (Ahmed and Othman, 2013; 
Fauzi et al., 2011; Ghashm et al., 2010; Halima et al., 2010; Kannan et al., 2009; Khalil 
et al., 2010; Khalil et al., 2011a; Khalil et al., 2011b; KirnpalKaur et al., 2011; Kishore 
et al., 2011; Mohamed et al., 2010; Nasir et al., 2010; Tan et al., 2009; Tumin et al., 
2005). Meanwhile as for Akasia, source of nectar is extraflorial. Thus it is continuously 
available. Comparing with Tualang in which the source of nectar is multifloral. As a 
result, its availability depends on flowering season. In addition, source of nectar are also 
available in large scale as availability of Acasia tree in large magnitude for manufacture 
of paper. Furthermore Apis mellifera is one of the bee-rearing projects in USM which is 
commercialised. As for Kelulut, it is unique as it is the only stingless bee. It is also 
under USM bee-rearing project. Thus availability of honey is not an issue.  
 
1.3 HONEY AND OTOMYCOSIS 
Very limited studies done overseas, demonstrate antifungal activity of honey. 
They used their local honey (Boukraa and Bouchegrane, 2007; Candiracci et al., 2012; 
DeMera and Angert, 2004; Estevinho et al., 2011; Feas and Estevinho, 2011; Irish et 
al., 2006; Koc et al., 2009;  Moussa et al., 2011; Moussa et al., 2012a; Moussa et al., 
2012b; Ngatu et al., 2011; Obaseiki-Ebor and Afonya, 1984; Theunissen et al., 2001). 
On the other hand, there were studies that document selected fungal resistant on honey 
(Kuncic et al., 2012; Lusby et al., 2005).  
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To best of our knowledge, based on research and English literature review, this 
will be the first study to reveal the antifungal properties of different types of Malaysian 
local honey to pathogenic fungi of otomycosis, specifically to A. niger and C. Albicans. 
Both are the most common cause for otomycosis. We hope with this effort we will be 
able to determine the antifungal effect of our local honey on pathogenic fungi of 
otomycosis, which are easily available and will subsequently be useful in the 
management of otomycosis, with added value to the international effort in this field.  
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CHAPTER 2 
 
OBJECTIVES 
 
2.1 General Objective:  
 
To study the antifungal effect of three types of Malaysian local honey (Tualang, Kelulut 
and Akasia) on Aspergillus niger and Candida albicans  
 
2.2 Specific Objectives: 
1) To determine the antifungal effect of three different honeys on Aspergillus niger 
 
2) To determine the antifungal effect of three different honeys on Candida albicans 
 
3) To determine the lowest concentration with antifungal effect and total inhibitory 
concentration of each honey on Aspergillus niger  
 
4) To determine the lowest concentration with antifungal effect and total inhibitory 
concentration of each honey on Candida albicans 
 
5) To establish the type of honey with strongest antifungal effect 
 
2.3 Research Hypothesis 
 
Different type of Malaysian honey has antifungal effect at different concentrations 
against Aspergillus niger and Candida albicans, which are known to be the common 
causative organisms for otomycosis.  
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CHAPTER 3 
 
METHODOLOGY 
 
3.1 Study design: This is a laboratory-controlled prospective study. In this study 
different concentrations of each honey will be studied in vitro, for their anti fungal 
activity on fungal isolates of Aspergillus niger and Candida albicans.    
 
3.2 Time and setting  
Duration of study: 7 months (From December 2013 till June 2014). 
Setting:  This study conducted under well-controlled environment in the Medical 
Microbiology and Pharmacology laboratories in the School of Medical Sciences, 
Universiti Sains Malaysia Health Campus, Kubang Kerian, Malaysia. It was carried out 
after obtaining approval from the University Human Ethical Committee. 
 
3.3 Materials 
The materials used in this study include: 
1. Three different types of honey – Tualang, Acasia and Kelulut 
2. Fungal isolates (Aspergillus niger  and  Candida albicans)   
3. Sabouraud Dextrose Agar (SDA) plate 90mm (Oxoid-CM 0041(R)) and 
Sabouraud Dextrose Agar (SDA) powder 
4. Plate 
5. BD PhoenixSpec(R) Nephelometer and Vortex 
6. Pipette and tip  
7. Distilled sterile water 
8. Sterile tube 
9. Hockey stick and Bunsen burner 
10. Alcohol 70% 
11. Sterile gloves 
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3.4 Method 
 
3.4.1 Honey preparation 
The Tualang Honey used in this study was obtained from Federal Agriculture 
Marketing Authority (FAMA), Kedah, Malaysia. Meanwhile, for Acasia honey and 
Kelulut honey the supply were from USM-BJIM Project (Medicinal Trigonal Bee 
Rearing project). All this honeys were subjected for sterilization with gamma-irradiation 
at a dose of 25kGy followed by sterility test. This radiation dose was sufficient to 
achieve sterility while preserving its antimicrobial properties which is heat-labile 
(Molan and Allen, 1996). 
 
Figure 3.1: Three types of honey (Tualang, Kelulut, Acasia) used in this study were 
subjected to gamma-irradiation and kept in the glass bottle and dark place. 
 
Honeys were kept in glass bottles and stored in the dark at room temperature 
because both hydrogen peroxide and glucose oxidase are light sensitive (Mousaa et al., 
2012a; White et al., 1963).  
 
3.4.1.1  Inclusion criteria 
1) Honeys supplied from either FAMA or USM-BJIM Project through 
Pharmacology department were only used.   
2) Honeys are kept in glass bottles and dark room. 
3) Honeys are sterilized with gamma-irradiation. Subsequently, it passes sterility 
test when there is no growth on SDA (control) when honey incorporated. 
4) Sterility of the equipment maintained throughout research. 
5) Consistent temperature in laboratory setting. 
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3.4.1.2 Exclusion criteria: 
1) Honey from other sources. 
2) Honey which does not undergo sterilisation, were not used to avoid 
contamination. 
3) Honey which has fungal growth on SDA, were not used because of the 
contamination with fungal. 
4) Honey which are exposed to sunlight/ not kept properly in dark room, were not 
used. As it may already lost its antifungal ability. 
 
3.4.2 Fungal strains  
The fungal isolates of Aspergillus niger and Candida albicans used in this study 
were obtained from patients attending Otorhinolaryngology – Head and Neck Surgery 
out-patient clinic of Hospital Universiti Sains Malaysia (HUSM). These are patients 
with symptoms and signs of otomycosis, without prior installation of 
antibiotic/antifungal ear drop. Swabs were taken from ear and spread on SDA for 
culture. Ready made SDA  plates were used to avoid contamination and to maintain 
standard. Plates were wrapped in parafilm to ensure secure closure, thus avoiding 
contamination.  
 
Figure 3.2: Sterile swab stick used to get ear swab from ear (left). Note the tip is slim 
for narrow ear canal. The stick then was lawn on petri dish (right) with Sabouraud 
Dextrose Agar (Oxoid-CM 0041
(R)
). It is used for the cultivation of fungi. The parafilm 
(white arrow) was used to wrap the plate. 
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It was then sent immediately to Microbiology Department. Each of isolates was 
then evaluated. Any SDA which grew Aspergillus niger or Candida albicans were then 
maintained and used for this study. In total, cultures were taken from 20 patients, with 
10 patients for each fungi. 
 
For SDA which grew Candida albicans, it is kept in refrigerator (2
0
C - 8 
0
C) 
until testing was performed (Figure 3.3). Meanwhile for SDA which grew Aspergillus 
niger, part of the agar (approximately 1x1cm) were cut and maintained in sterile 
distilled water in room temperature until testing was performed (Figure 3.4). This is to 
avoid overgrowth and spillage of Aspergillus niger  that grows rapidly when maintained 
in media that kept in refrigerator. 
 
Figure 3.3: Candida albicans growth in SDA (left). The plates were kept in refrigerator 
(right) until testing was performed.  
 
Figure 3.4: Aspergillus niger growth in SDA (left). Part of the agar maintained in sterile 
distilled water in room temperature until testing was performed (right).  
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Both were then sub cultured before testing was performed. Each individual 
fungal was coded for easier labelling on petri dish later. Examples Aspergillus niger, lab 
code F2159, code used A. Meanwhile for Candida albicans, lab code C673, code used 
B.   
 
3.4.3 Inoculums preparation and standardization 
Preparations of inoculums were done in Biohazard Safety Cabinet (Figure 3.5). 
This will prevent any hazardous material from spreading to the laboratory spaces. Its 
HEPA (High-efficiency particulate air) filter will remove harmful bacteria and viruses. 
It has warning alarm if the protective glass opened beyond safety range.  
 
Figure 3.5: NuAire 
(R)
 Class II, Type A2 Biosafety cabinet (NuAire, USA). 
 
Fungi needed for this study were grown by subcultures in SDA for three days in 
incubator. The incubator maintains optimal temperature, humidity, oxygen and carbon 
dioxide content inside. Therefore this will provide conducive environment for fungal 
growth. 
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Figure 3.6: Memmert
(R)
 Standard Incubator (Memmert, Germany) with temperature 30 -
35
0
C. 
Stock suspensions of Aspergillus niger were prepared from sporulating 3-day-
old cultures. Colonies were covered with 5 ml sterile distilled water and the surface was 
scraped with sterile cotton swab. While doing this the plate cover was open slightly to 
avoid contamination. The mixture of conidia and hyphal fragments were filtered with 
sterile gauze and collected in sterile specimen container (Figure 3.7). This procedure 
removed the majority of the hyphae, producing inocula composed mainly of spores 
(Petrikkou et al., 2001). 
 
 
Figure 3.7 : Subcultured Aspergillus niger bathed with sterile distilled water (left) to 
produce  suspension which was filtered with sterile gauze and collected in sterile 
specimen container (right). 
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Subsequently, the inoculum suspensions were transferred adequately into a 
sterile tube containing 3 ml of distilled water and were mixed well using Vortex. The 
tubes have been sterilised by autoclave. Sterile tubes are important to avoid 
contaminations of other organism which will interfere with the results.  
   
Figure 3.8: Sterile specimen container (left), autoclaved sterilized tubes (centre) and 
sterile cotton swab (right) used in this study. 
 
 The final inoculums suspension density was adjusted to the turbidity of 0.5 
McFarland standard using Nephelometer, which is equivalent to 0.5-5x10
6
 cfu/ml.  
 
Figure 3.9: BD PhoenixSpec
(R)
  Nephelometer 440910 (Becton Dickson & Company, 
USA), on left used to measure turbidity and Vortex, on right to ensure proper mixture of 
suspension.  
 
Meanwhile for Candida albicans, it was also prepared from sporulating 3-day-
old cultures. The colony was scraped with sterile cotton swab. This were also done with 
the upper lids of plates were slightly lifted to avoid contamination. Following this, the 
cotton swab was dipped into a sterile tube containing 3 ml of distilled water and firmly 
rotated to mix well the colony and water.  The swab was removed then, while the tube 
